Thailand Medical News - For All The Latest Breaking Medical News, Health News, Research News, COVID-19 News, Outbreak News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Heart And Cardiology News, Epigenetic News, Cancer News,

COVID-19 News - Ferroptosis  May 27, 2023  9 months, 1 day, 22 hours, 29 minutes ago

Ferroptosis And Its Role In Multi-Organ Complications In COVID-19: Unveiling Potential Therapies

facebook sharing button Share
twitter sharing button Tweet
linkedin sharing button Share
Ferroptosis And Its Role In Multi-Organ Complications In COVID-19: Unveiling Potential Therapies
COVID-19 News - Ferroptosis  May 27, 2023  9 months, 1 day, 22 hours, 29 minutes ago
COVID-19 News: The COVID-19 pandemic caused by the SARS-CoV-2 virus has had a profound impact on global health, resulting in millions of deaths and infections worldwide. While respiratory symptoms are the primary manifestations of COVID-19, severe cases can lead to multi-organ complications and persistent post-COVID-19 symptoms as shown in various past studies, case reports and also COVID-19 News coverages.

Multi-organ complications of COVID-19. COVID-19 involves the lungs, heart, brain, kidneys, liver, and gastrointestinal tract. Pulmonary symptoms include dyspnea and chest pain; common cardiovascular complications include myocardial injury, acute myocardial infarction (AMI), and arrhythmia; brain complications often include cognitive impairment, insomnia, anxiety, and other central nervous symptoms; acute kidney injury (AKI) and renal dysfunction are the main renal manifestations; anorexia, nausea, vomiting, diarrhea, abdominal pain, and liver injury are common digestive symptoms of COVID-19. The mechanism of COVID-19 multi-organ complications may be correlated with ferroptosis.
Understanding and mitigating these complications have become crucial in the battle against the pandemic.
A new study by researchers from China suggests that ferroptosis, a regulated form of cell death involving altered iron metabolism and oxidative stress, may play a role in the multi-organ complications observed in COVID-19 patients. This new study explores the mechanisms of ferroptosis, its association with COVID-19 complications, and the potential for ferroptosis inhibitors as a supplementary treatment for COVID-19.
Ferroptosis also known as Oxytosis, is a type of programmed cell death dependent on iron and characterized by the accumulation of lipid peroxides, and is genetically and biochemically distinct from other forms of regulated cell death such as apoptosis. Ferroptosis is initiated by the failure of the glutathione-dependent antioxidant defenses, resulting in unchecked lipid peroxidation and eventual cell death.
The Link Between Ferroptosis and COVID-19
COVID-19 affects multiple organs, including the heart, brain, kidneys, gastrointestinal tract, and liver. Ferroptosis, characterized by iron-dependent lipid peroxidation, has emerged as a potential underlying mechanism contributing to the pathogenesis of COVID-19. The dysregulated cell death associated with ferroptosis can lead to uncontrolled cellular damage and immune responses, contributing to the multi-organ complications observed in severe COVID-19 cases.
Studies have shown a strong association between ferroptosis-related factors and COVID-19 complications, suggesting a possible connection.
Molecular Mechanisms of Ferroptosis
Ferroptosis is driven by the interplay of oxidation and antioxidant pathways. The oxidation mechanisms involve lipid peroxidation, primarily of polyunsaturated fatty acids (PUFAs) in cell membranes, mediated by enzymes such as lipoxygenases (LOXs) and oxygen-centered free radicals. Iron metabolism plays a crucial role, as iron overload and imbalances in iron homeostasis contribute to lipid peroxidation and ferroptosis. The antioxidant system, including glutathione (GSH) and glutathione peroxidase 4 (GPX4), is essential in preventing ferroptosis by controlling intracellular oxidation levels.
Ferroptosis and Multi-Organ Complications in COVID-19
COVID-19 patients often experience multi-organ complications, such as myocardial injury, cognitive impairment, acute kidney injury, gastrointestinal dysfunction, and liver damage. The association between SARS-CoV-2 infection and ferroptosis-related pathways is supported by elevated pro-inflammatory cytokines, oxidative stress, and altered iron metabolism observed in COVID-19 patients. The dysregulation of iron homeostasis and the accumulation of lipid peroxides may contribute to the severity of COVID-19 and its multi-organ manifestations.
Potential Therapies Targeting Ferroptosis in COVID-19
Inhibiting ferroptosis shows promise as a potential therapeutic strategy for reducing COVID-19 complications. Various approaches can be considered, including oxidase inhibitors and lipid autoxidation inhibitors. Oxidase inhibitors reduce the production of reactive oxygen species (ROS) and inhibit ferroptosis. Lipid autoxidation inhibitors, such as Fer-1 and Lip-1, trap peroxyl radicals and reduce lipid peroxide accumulation. Iron depletion methods, such as using iron chelators like DFO, L1, and DFX, can interrupt the iron-catalyzed lipid peroxidation process. Enhancing the antioxidant system through GPX4 activators and selenium supplementation may also inhibit ferroptosis. Antioxidants can help counteract the excessive oxidative stress and lipid peroxidation associated with ferroptosis. Compounds such as vitamin E, N-acetylcysteine (NAC), and ferrostatins have shown potential in preclinical models of ferroptosis and could be explored for their efficacy in COVID-19.
Understanding the association between ferroptosis and multi-organ complications in COVID-19 provides valuable insights into potential therapeutic strategies for reducing the severity and long-term impact of COVID-19. By targeting ferroptosis-related pathways, it may be possible to mitigate the severity of the disease, reduce long-term organ damage, and improve patient outcomes. However, further research and clinical trials are necessary to establish the effectiveness of these strategies in the context of COVID-19.
The study findings were published in the peer reviewed journal: Frontiers in Genetics.
For the latest COVID-19 News, keep on logging to Thailand Medical News.
Read Also:,-causing-damage-to-heart,-liver-and-kidneys-the-phytochemical-trigonelline-helps


Jun 10, 2023  9 months ago
COVID-19 News - DNA Methylation - Asymptomatic SARS-CoV-2 Infections
Sep 08, 2022  1 year ago
Source- Medical News - COVID-19 Research - Impaired Pain Modulation
Aug 04, 2022  2 years ago
Source: Medical News - SARS-CoV-2 & Cancer
Aug 13, 2020  4 years ago
Source: Supplements For COVID-19
Jun 10, 2020  4 years ago
Source: COVID-19 Research